SecSonar.com

UFP Technologies, Inc. (UFPT)

UFP Technologies, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

UFP Technologies, Inc. (UFPT) is a Medical - Devices company based in US with a market capitalization of $1.7B. Revenue grew 19.5% year-over-year and the company generated $79M in free cash flow. This page tracks UFPT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 4.15K employees · IPO Dec 17, 1993

Valuation

Valuation & price

$213.95 · as of May 17, 2026 · -21.4% vs 52w high

24.4

P/E ratio

Latest-FY diluted EPS

4.12

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$272$231$189Jul 25Dec 25Jul 26Jul 7, 25$241.07Jul 9, 25$247.56Jul 11, 25$242.52Jul 15, 25$231.20Jul 17, 25$232.00Jul 21, 25$226.83Jul 23, 25$243.32Jul 25, 25$241.92Jul 29, 25$237.67Jul 31, 25$226.39Aug 4, 25$226.27Aug 6, 25$213.60Aug 11, 25$213.56Aug 13, 25$226.61Aug 15, 25$219.54Aug 19, 25$217.39Aug 21, 25$219.56Aug 25, 25$220.94Aug 27, 25$214.57Aug 29, 25$210.16Sep 3, 25$203.62Sep 5, 25$207.29Sep 9, 25$204.06Sep 11, 25$201.37Sep 16, 25$203.13Sep 18, 25$201.60Sep 22, 25$195.59Sep 24, 25$193.37Sep 26, 25$193.54Sep 30, 25$199.60Oct 2, 25$195.46Oct 6, 25$201.93Oct 8, 25$196.41Oct 10, 25$191.32Oct 14, 25$199.34Oct 16, 25$193.01Oct 21, 25$201.23Oct 23, 25$200.20Oct 27, 25$200.01Oct 29, 25$189.37Oct 31, 25$192.64Nov 4, 25$223.04Nov 6, 25$222.77Nov 10, 25$234.53Nov 12, 25$237.29Nov 14, 25$231.58Nov 18, 25$218.58Nov 20, 25$209.85Nov 25, 25$229.74Nov 28, 25$226.69Dec 2, 25$219.08Dec 4, 25$216.23Dec 8, 25$215.79Dec 10, 25$213.79Dec 12, 25$219.44Dec 16, 25$217.74Dec 18, 25$224.86Dec 22, 25$229.67Dec 24, 25$235.54Dec 29, 25$235.92Jan 2, 26$223.40Jan 6, 26$245.88Jan 8, 26$255.42Jan 12, 26$258.89Jan 14, 26$260.51Jan 16, 26$260.52Jan 21, 26$265.17Jan 23, 26$258.68Jan 27, 26$251.58Jan 29, 26$246.78Feb 2, 26$255.87Feb 4, 26$255.29Feb 9, 26$265.41Feb 11, 26$263.44Feb 13, 26$245.81Feb 18, 26$245.83Feb 20, 26$233.49Feb 24, 26$240.57Feb 26, 26$215.67Mar 2, 26$204.30Mar 4, 26$203.99Mar 6, 26$208.92Mar 10, 26$214.86Mar 12, 26$204.31Mar 17, 26$205.65Mar 19, 26$196.98Mar 23, 26$188.76Mar 25, 26$190.07Mar 27, 26$189.45Mar 31, 26$193.60Apr 2, 26$192.02Apr 7, 26$188.70Apr 9, 26$203.60Apr 13, 26$203.39Apr 15, 26$196.22Apr 17, 26$202.38Apr 22, 26$203.74Apr 24, 26$200.06Apr 28, 26$195.25Apr 30, 26$191.63May 4, 26$192.55May 6, 26$218.20May 8, 26$230.55May 12, 26$220.59May 14, 26$220.94May 18, 26$217.22May 20, 26$224.73May 22, 26$228.97May 28, 26$227.99Jun 1, 26$218.13Jun 3, 26$218.34Jun 5, 26$223.87Jun 9, 26$231.12Jun 11, 26$238.60Jun 15, 26$233.67Jun 17, 26$227.68Jun 22, 26$233.30Jun 24, 26$242.95Jun 26, 26$259.80Jul 2, 26$272.36
$185.2852-week range$272.36
Loading valuation history…

Fundamentals

Key fundamentals

$1.7B

Market cap

19.5%

Revenue growth (YoY)

28.3%

Gross margin

$79M

Free cash flow (USD)

$134.2M

Net debt

0.5%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$146.1MFY 2017$147.8MFY 2018$190.5MFY 2019$198.4MFY 2020$179.4MFY 2021$206.3MFY 2022$353.8MFY 2023$400.1MFY 2024$504.4MFY 2025$602.8M
$146.1M$602.8M

Free cash flow by year

2016 → 2025

FY 2016$2.1MFY 2017$7.1MFY 2018$15.9MFY 2019$25.5MFY 2020$20.7MFY 2021$8.9MFY 2022$4.0MFY 2023$30.8MFY 2024$56.9MFY 2025$79.0M
$2.1M$79M

Gross margin by year

2021 → 2025

FY 202124.8%FY 202225.5%FY 202328.1%FY 202429.1%FY 202528.3%
24.8%28.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $287KFELDMANN CYNTHIA L · Director · $287.1KJun 15, 2026Filing
  • 8-K eventPerformance Share Award GrantedJun 10, 2026Filing
  • 8-K eventInvestor Presentation UpdateJun 8, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 5, 2026Filing
  • 8-K eventExecutive RetirementMay 26, 2026Filing
  • Insider sellInsider Sell $635KCROTEAU DANIEL C · Director · $635KMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 4, 2026Filing

Questions

Frequently asked questions

What is UFP Technologies, Inc.'s market cap?

UFP Technologies, Inc. (UFPT) has a market capitalization of $1.7B.

What is UFPT's P/E ratio?

UFPT trades at a price-to-earnings ratio of 24.4, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is UFPT's price-to-book (P/B) ratio?

UFPT trades at 4.12 times book value per share.

Are insiders buying UFPT stock?

SEC Form 4 filings show no open-market insider buys at UFP Technologies, Inc. in the last 90 days (2 sells).

Same arena

Related companies in Medical - Devices

PRCT

PROCEPT BioRobotics Corporation

$1.5B

AXGN

AxoGen, Inc.

$2.1B

AHCO

AdaptHealth Corp.

$1.4B

ESTA

Establishment Labs Holdings Inc.

$2.1B

ENOV

Enovis Corporation

$1.3B

IART

Integra LifeSciences Holdings Corporation

$1.3B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.